CBD companies have had to adapt marketing strategies as the COVID-19 pandemic has developed. The pandemic and the associated practice of social distancing have overtaken 4/20, the biggest promotional day for cannabis ...
Closures of non-essential retail will be far and away the largest factor impacting on CBD markets across the globe. It is estimated that up to 90% of offline sales in markets such as the UK...
The US Drug Enforcement Administration (DEA) has removed Epidiolex, the only CBD drug so far approved by the US Food and Drug Administration (FDA), from its list of controlled substances ...
CBD entrepreneur Christina DiArcangelo tells CBD-Intel that businesses should be using the slowdown to study, reflect, plan – and “get ahead of the ball” ...
The wider impact of COVID-19 on the CBD sector in the US remains confused in the short term and largely a mystery in the longer term as companies scramble to gather information ...
By combining our online and offline market analysis, we have identified the most prevalent brands of each of the following nine countries: Austria, France, Germany, Greece, Italy, Netherlands, Switzerland, the UK and the US. 37...
Legislative measures are on hold in half the states of the US due to the COVID-19 emergency, with most suspending activity until at least mid-April ...
Industry organisations have responded in anger to continued claims being made by some companies about the supposed power of cannabinoids in tackling COVID-19 ...
Also: GW suggests another possible use for Epidyolex; Lawsuit alleges hemp plants were contaminated with pesticide; Elixinol rebrands to move away from medicinal image; Kentucky hemp business goes bust ...
This presentation provides an overview of the CBD consumer segmentation, including the current user profile and the reasons for use. This analysis is the perfect aid for understanding customer characteristics, and it offers insights for...
Expected retail closures will have a significant impact on the distribution of CBD products in most major markets, according to analysis of CBD-Intel data ...
Bogus claims that products containing CBD may have any beneficial effects in treating or warding off coronavirus risk the wrath of authorities in the US – and could ultimately damage CBD's reputation ...
Lenka Hajnovicova, one of CBD-Intel’s legal analysts, presented the latest challenges and trends in light of the current regulatory framework of the cannabidiol sector at the Canapa Mundi in Rome on 23rd February. She discussed...
A company has launched a hand sanitiser infused with CBD, a US wellness brand is selling what it claims is the world’s first CBD blanket, and Dog-sledding champion Lance Mackey has admitted to giving his...
As the COVID-19 pandemic continues to affect people across the world, a swathe of CBD-related events have been called off or postponed. Here is a list of some of the major ones, with dates and...
Our managing director, Tim Phillips, recently discussed global CBD opportunities during the USA CBD Expo in Las Vegas in February. He explored medical and recreational cannabis and their developments, CBD as an ingredient in health...
Investors want to see a proven track record from a CBD company more than anything else, according to the organiser of an investor summit to be held in London later this month ...
German authorities and a major European hemp association have disagreed on the implications of correspondence regarding the novel status of hemp extracts ...
The first CBD-Intel Breakfast Briefing will be held in our home city of Barcelona on 13th March, to coincide with Europe’s largest cannabis trade show, Spannabis, and is free to our valued clients and subscribers...